← Leaderboards
Winston E Thompson
Morehouse School Of Medicine
$6,393,744
Attributed
$8,099,285
Total exposure
11
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $848.4K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,099,285 · 11
By mechanism
U01$2,165,453 · 2
U54$1,994,036 · 3
R01$1,993,085 · 2
R25$1,026,442 · 1
S06$574,075 · 1
G12$346,194 · 2
Top collaborators
- Neil Sidell6 shared
- Charles A. Easley5 shared
- Stacy L Mcallister1 shared
- Luis Villacorta1 shared
Most similar at Morehouse School Of Medicine
Same institution · by research overlap
- Minerva T Garcia-Barrio$2,553,672
Others in their field
Top investigators on “Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$677,505,141
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$532,027,174
- Barton F Haynes · Duke University$497,761,007
- Jeffrey P Krischer · University Of South Florida$397,532,270
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Research focus
ResponseLaboratoriesFutureIn VivoMediator Of Activation ProteinHormonalWomanReportingMolecularDesignApoptosisGrowthLesionInfertilityProgramsAffectRattusCareerCenter For Translational Science ActivitiesCellsLaboratory ResearchEstrogensInvestigationMentors
Grant awards (34)
STING inhibition as a therapeutic target for endometriosis$578,397
R01 · FY2025 · HD
Frontiers in Environmental Science and Health (FrESH$201,683
R25 · FY2025 · ES · contact PI
Frontiers in Environmental Science and Health (FrESH$203,338
R25 · FY2024 · ES · contact PI
Frontiers in Environmental Science and Health (FrESH$204,938
R25 · FY2023 · ES · contact PI
Reduced DNA Repair Capacity Leads to Increased Risk of Uterine Fibroids (UFs) in African Americans$359,169
U54 · FY2022 · MD · contact PI
Frontiers in Environmental Science and Health (FrESH$206,487
R25 · FY2022 · ES · contact PI
Reduced DNA Repair Capacity Leads to Increased Risk of Uterine Fibroids (UFs) in African Americans$384,930
U54 · FY2021 · MD · contact PI
Frontiers in Environmental Science and Health (FrESH$209,996
R25 · FY2021 · ES · contact PI
Reduced DNA Repair Capacity Leads to Increased Risk of Uterine Fibroids (UFs) in African Americans$386,664
U54 · FY2020 · MD · contact PI
Reduced DNA Repair Capacity Leads to Increased Risk of Uterine Fibroids (UFs) in African Americans$388,367
U54 · FY2019 · MD · contact PI
Reduced DNA Repair Capacity Leads to Increased Risk of Uterine Fibroids (UFs) in African Americans$412,400
U54 · FY2018 · MD · contact PI
1/2-Atlanta Center for Translational Research in Endometriosis (ACTRE)$277,045
U01 · FY2014 · HD
Mechanism of Action of Prohibitin in Ovarian Cell Function$266,965
R01 · FY2014 · HD · contact PI
2/2-Atlanta Center for Translational Research in Endometriosis (ACTRE)$252,913
U01 · FY2014 · HD · contact PI
1/2-Atlanta Center for Translational Research in Endometriosis (ACTRE)$273,139
U01 · FY2013 · HD
Mechanism of Action of Prohibitin in Ovarian Cell Function$266,798
R01 · FY2013 · HD · contact PI
2/2-Atlanta Center for Translational Research in Endometriosis (ACTRE)$249,353
U01 · FY2013 · HD · contact PI
1/2-Atlanta Center for Translational Research in Endometriosis (ACTRE)$290,641
U01 · FY2012 · HD
Mechanism of Action of Prohibitin in Ovarian Cell Function$287,429
R01 · FY2012 · HD · contact PI
2/2-Atlanta Center for Translational Research in Endometriosis (ACTRE)$270,354
U01 · FY2012 · HD · contact PI
2/2-Atlanta Center for Translational Research in Endometriosis (ACTRE)$272,008
U01 · FY2011 · HD · contact PI
Mechanism of Action of Prohibitin in Ovarian Cell Function$295,290
R01 · FY2010 · HD · contact PI
2/2-Atlanta Center for Translational Research in Endometriosis (ACTRE)$280,000
U01 · FY2010 · HD · contact PI
Mechanism of Action of Prohibitin in Ovarian Cell Function$298,206
R01 · FY2009 · HD · contact PI
ROLE OF PROHIBITIN DURING OVARIAN FOLLICULAR DVMT: MINORITY REPRODUCTIVE HEALTH$114,742
G12 · FY2006 · RR · contact PI
ROLE OF PROHIBITIN DURING OVARIAN FOLLICULAR DVMT: MINORITY REPRODUCTIVE HEALTH$90,956
G12 · FY2005 · RR
PILOT PROJECT 3$62,506
U54 · FY2005 · CA
ROLE OF PROHIBITIN DURING OVARIAN FOLLICULAR DVMT: MINORITY REPRODUCTIVE HEALTH$140,496
G12 · FY2004 · RR
ROLE OF PROHIBITIN IN FOLLICULAR DEVELOPMENT$0
U54 · FY2002 · HD
MOLECULAR ANALYSIS OF CYSTOGENESIS$159,403
S06 · FY2001 · GM
ROLE OF PROHIBITIN IN FOLLICULAR DEVELOPMENT$0
U54 · FY2001 · HD
MOLECULAR ANALYSIS OF CYSTOGENESIS$159,403
S06 · FY2000 · GM
MOLECULAR ANALYSIS OF CYSTOGENESIS$159,403
S06 · FY2000 · GM
MOLECULAR ANALYSIS OF CYSTOGENESIS$95,866
S06 · FY2000 · GM